Innovate Partnering with University of Maryland to Investigate Larazotide’s Potential to Treat IBD

Innovate Partnering with University of Maryland to Investigate Larazotide’s Potential to Treat IBD
Innovate Biopharmaceuticals Inc. will collaborate with a researcher at the University of Maryland School of Medicine to develop larazotide as a potential treatment for diseases that affect the intestinal barrier, the company announced. The intestine is composed of a layer of cells normally held tightly together to stop any foreign organisms from breaking the intestinal

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *